Dr. Harigopal on Advances With Breast Cancer Pathology

Malini Harigopal, MD
Published: Wednesday, Sep 21, 2016


Malini Harigopal, MD, associate professor of Pathology, interim director of Breast Pathology, Yale School of Medicine, Yale Cancer Center, discusses the advancements in the pathology of breast cancer.

The most important change is the evaluation of the receptor status of breast cancer. Additionally, the role of the pathologist has moved beyond diagnosing breast cancer to assessing the receptor expression—HER2, progesterone receptor or estrogen receptor (ER)—on breast cancer. This will determine whether an individual patient will respond to treatment or not.

In a breast cancer that strongly expresses ER, patients are likely to respond to endocrine therapy. If ER expression is not present, then other treatment approaches must be looked into, Harigopal explains.

Malini Harigopal, MD, associate professor of Pathology, interim director of Breast Pathology, Yale School of Medicine, Yale Cancer Center, discusses the advancements in the pathology of breast cancer.

The most important change is the evaluation of the receptor status of breast cancer. Additionally, the role of the pathologist has moved beyond diagnosing breast cancer to assessing the receptor expression—HER2, progesterone receptor or estrogen receptor (ER)—on breast cancer. This will determine whether an individual patient will respond to treatment or not.

In a breast cancer that strongly expresses ER, patients are likely to respond to endocrine therapy. If ER expression is not present, then other treatment approaches must be looked into, Harigopal explains.



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Cancer Summaries and Commentaries™: Update from Chicago: Advances in the Treatment of Breast CancerJul 31, 20181.0
Community Practice Connections™: Medical Crossfire®: Translating Lessons Learned with PARP Inhibition to the Treatment of Breast Cancer—Expert Exchanges on Novel Strategies to Personalize CareAug 29, 20181.5
Publication Bottom Border
Border Publication
x